Pfizer Loses Bid To Invalidate Bayer's Bovine Drug Patent
An Illinois federal judge on Tuesday blocked Pfizer Inc.'s bid to have Bayer Healthcare LLC's patent for a bovine respiratory disease drug declared invalid, finding Bayer's claims for a single, high-dose...To view the full article, register now.
Already a subscriber? Click here to view full article